Patents Assigned to Interlab Corporation
  • Xanthone analogs for the treatment of infectious diseases
    Patent number: 5977077
    Abstract: Therapeutic compositions for the treatment of infectious diseases are disclosed. These compositions comprise xanthones and xanthone derivatives, such as 2,3,4,5,6-pentahydroxyxanthone. Also disclosed are methods for the treatment of infectious diseases using such compounds.
    Type: Grant
    Filed: March 20, 1996
    Date of Patent: November 2, 1999
    Assignee: Interlab Corporation
    Inventors: Rolf Walter Winter, Michael Kevin Riscoe, David J. Hinrichs